Noile-Immune Biotech (TSE:4893) Interest Expense : 円0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Noile-Immune Biotech's interest expense for the three months ended in Mar. 2024 was 円 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円0.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Noile-Immune Biotech's Operating Income for the three months ended in Mar. 2024 was 円 -339.3 Mil. Noile-Immune Biotech's Interest Expense for the three months ended in Mar. 2024 was 円 0.0 Mil. Noile-Immune Biotech has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Noile-Immune Biotech Interest Expense Historical Data

The historical data trend for Noile-Immune Biotech's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Interest Expense Chart

Noile-Immune Biotech Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Expense

Noile-Immune Biotech Quarterly Data
	Dec20	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial				-	-	-	-	-

Noile-Immune Biotech Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

Noile-Immune Biotech (TSE:4893) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Noile-Immune Biotech's Interest Expense for the three months ended in Mar. 2024 was 円0.0 Mil. Its Operating Income for the three months ended in Mar. 2024 was 円-339.3 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was 円0.0 Mil.

Noile-Immune Biotech's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Noile-Immune Biotech had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Noile-Immune Biotech Inc has no debt.

Noile-Immune Biotech (TSE:4893) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012

Website

https://www.noile-immune.com

Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines